Loading
CP
Celon Pharma S.A. Stock: price and insider trades · Poland
1 insider bought shares over the last 90 days, the latest by Justyna Rejmak, filed 28 Aug 2026.
Celon Pharma S.A.: what insiders have been doing
Celon Pharma S.A. belongs to the Health Care sector. Filings by its managers are published through KNF. Between 23 October 2025 and 23 October 2026, 2 insiders published 2 filings.
The flow runs one way only: 1 insider bought (1 purchase) and nobody sold on the market. The totals do not cover 1 filing with an undisclosed amount. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.
The most recent open-market purchase was published on 28 August 2026, 56 days ago.
Compared with its exchange (554 companies, median 3 filings), a count of 2 filings is below the norm. Looking back to 2026, when coverage begins, insiders filed 1 purchase and no sales.
Other companies in the same sector with recent insider buying flagged by our signals: Dynavox Group AB and EssilorLuxottica. These figures are compiled from regulatory filings published by KNF. They describe what insiders did and are not a recommendation.
Insider Decl.
2
Thresholds
n/a
Buy Volume
n/a
1 ops. · all time
Sell Volume
n/a
n/a
Who traded when
BuySaleJustyna Rejmak1 buy
Fundamental score
Ranked 15,154 of 26,286 companies
47.0
score / 100
Value35
Quality59
FCF yld2.3%
Earn yld-7.7%
EV/EBITDA·
ROE24%
Gross mgn64%
Net mgn-45%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
PLN 19.50
Analyst consensus
5 analysts3.40/5
PLN 16.00Target PLN 20.38(+5%)PLN 25.20
Income statement
RevenuePLN 177.5M
Gross profitPLN 114.4M64% margin
EBITDA-PLN 24.9M-14% margin
Net income-PLN 79.4M41.5% margin
Valuation
PER (trailing)9.3x
PER (forward)-70.9x
P/Book2.1x
Beta0.62
Balance sheet & cash
Market capPLN 1.1B
Total debtPLN 16.9M
Free Cash FlowPLN 23.9M
Debt / Equity26%
Profitability & ownership
ROE24.2%
ROA-0.5%
% insiders55.7%
% institutions18.3%
Last declaration on 28 August 2026
Declarations2 total
▲
Executives
0KNF
●
Executives
0KNF
2 of 2 declarations
About Celon Pharma S.A.
Celon Pharma S.A. is a company focused on the development of innovative drugs in the healthcare and pharmaceutical sector. It is listed on the XWAR market.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
